Related Experiment Video
Updated: May 15, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Racial/ethnic differences in cancer risk after kidney transplantation
E C Hall1, D L Segev, E A Engels
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. ehall@jhsph.edu
Summary
Cancer risk after kidney transplantation varies by race and ethnicity. Black and Hispanic recipients showed different risks for certain cancers compared to white recipients, particularly kidney and prostate cancers.
Area of Science:
- Transplant Oncology
- Cancer Epidemiology
- Health Disparities
Background:
- Kidney transplant recipients face increased cancer risk.
- Existing data do not fully clarify if cancer risk disparities observed in the general population persist post-transplant.
Purpose of the Study:
- To investigate racial and ethnic differences in the risk of six common cancers among US kidney transplant recipients.
- To compare post-transplant cancer risks across racial/ethnic groups to general population patterns.
Main Methods:
- Analysis of 87,895 US kidney recipients from the Transplant Cancer Match Study (1992-2008).
- Evaluation of racial/ethnic variations in incidence rates and standardized incidence ratios (SIRs) for specific cancers.
- Comparison of cancer risk between Black, Hispanic, and White recipients.
Main Results:
- Black recipients had lower non-Hodgkin lymphoma risk but higher kidney and prostate cancer risk compared to White recipients.
- Hispanic recipients had lower risks for non-Hodgkin lymphoma, lung, breast, and prostate cancers.
- All racial groups showed increased kidney cancer risk post-transplant, with Black and Hispanic recipients experiencing a proportionally larger increase.
- Elevated prostate cancer risk post-transplant was observed only in Black recipients.
Conclusions:
- Racial/ethnic cancer risk patterns post-kidney transplantation largely mirror those in the general population.
- Significant differences in kidney and prostate cancer risk highlight the impact of end-stage renal disease and transplantation itself on these specific cancers.
- Further research is needed to understand the mechanisms behind these observed disparities.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...